The Motley Fool

Jed Lloren

I am a growth-oriented investor focusing on advances in technology and health care research (e.g. gene editing, genome sequencing, drug discovery). As a Freelance Writer for Motley Fool Canada, I enjoy being able to use my research and writing to help individual investors through their investment journey.

Stop Buying Stocks Based on a High Dividend Yield

Canadian investors continue to choose subpar dividend companies because of their affinity for high dividend yields. What should investors be focusing on instead? More »

Which 2 Stocks Will I Buy Next?

I am always thinking about the next moves I want to make in my portfolio. Which two companies am I considering adding to my... More »

2 Amazing Growth Stocks You Do Not Know About

In this article, I will provide two excellent growth stocks that you probably do not know about. More »

2 Industries Millennials Should Focus On

Two industries stand out among their peers in terms of potential growth. Which two industries do I think millennials in Canada should focus on? More »

Can You Guess Which 2 Stocks Generated the Most Gains in the 2010s?

You would think the two top performing stocks of the last decade would be start-up tech companies. However, they are in fact far from... More »

2 Lesser-Known Dividend Stocks for Your Portfolio

While everyone focuses on the latest tech IPOs, look at these two lesser-known companies. More »

Worried About Inflation? Real Assets Are a Proven Hedge

Adding real assets into your portfolio can provide a substantial hedge against inflation in your portfolio. More »

Why These 2 Stocks Look Even More Attractive Now

Lightspeed (TSX:LSPD) and Docebo (TSX:DCBO) are two of the hottest tech companies in Canada. Why am I more bullish than ever on them? More »

Kinaxis (TSX:KXS) Stock Has Been Flat Since June: Is it Still a Buy?

The company was a leader coming out of the March crash, but it hasn’t seen much movement lately. Should you still buy the company? More »

Could This New IPO Be the Next Millionaire-Maker Stock?

Find out which fintech company could be the next big Canadian growth story. More »